CHURCH KEVIN - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 5, 2024, CHURCH KEVIN's relationship to Athira Pharma, Inc. (ATHA) is Officer (CHIEF SCIENTIFIC OFFICER), and currently has 92,684 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ATHA insiders.

Data Source: SEC.
CHURCH KEVIN - Insider Non-Derivative Transactions of ATHA Common Stock
CHURCH KEVIN - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 6, 2024 Sell -- (Common Stock) 2525 0.57 92684
Sep 4, 2024 Acquisition -- (Common Stock) 10000 0 95209
May 21, 2024 Acquisition -- (Common Stock) 4953 1.34 85209
Jan 6, 2024 Sell -- (Common Stock) 2412 2.91 80256
Jan 5, 2024 Acquisition -- (Common Stock) 10000 0 82668
Nov 21, 2023 Acquisition -- (Common Stock) 3397 1.34 72668
May 19, 2023 Acquisition -- (Common Stock) 809 2.41 69271
Mar 25, 2023 M -- (Common Stock) 6410 1.35 68462
Jan 6, 2023 Sell -- (Common Stock) 2412 2.91 80256
Jan 5, 2023 Acquisition -- (Common Stock) 10000 0 82668
Nov 19, 2022 Acquisition -- (Common Stock) 657 2.74 62052